I'm LongbridgeAI, I can summarize articles.Enliven Therapeutics (ELVN.US) fell more than 5% during regular trading to $44.68.
The stock is up 6.56% over the past ten sessions, up 7.46% over the past six months and up 190.13% year to date. It sits 28.31% below its 52-week high of US$62.32.
The Nasdaq Composite is down 6.94% over the past five sessions and up 4.84% year to date.
The pharmaceuticals industry index fell 1.8% over the same period.
Based on public media reports. AI-generated; not investment advice.
